Posted in News
Ivonescimab (PD-1/VEGF) Received Priority Review from China’s NMPA for First-Line Treatment of PD-L1 Positive NSCLC
The Second Indication of Ivonescimab in NSCLC 2L+ EGFRm NSCLC Already Approved in May 2024 HONG KONG, Aug. 14, 2024 /PRNewswire/ — Akeso, Inc. (HKEX: 9926.HK) (“Akeso,”) today announced that the National Center for Drug Evaluation of the State Drug Administration of the People’s Republic…
14/08/2024
Posted in News
GOL announces 2Q24 Earnings Result
SÃO PAULO, Aug. 14, 2024 /PRNewswire/ — GOL Linhas Aéreas Inteligentes S.A. (B3: GOLL4), one of the leading airlines in Brazil and part of the ABRA Group, announced today its consolidated results for the second quarter of 2024 (2Q24). All information herein is presented in Reais (R$), in…
14/08/2024
Posted in News
14/08/2024
Posted in News
14/08/2024